{"transactions":[{"id":734250,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37291,"kind":"person","name":"Keefer David R","position":1,"cik":"0001825986","reported_name":"Keefer David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-17T17:16:00.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":16800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16800,"derivative":{"exercise_price":1.5,"exercise_date":"2027-06-16","expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":16800},"source":{"system":"sec-edgar","filing":"0001825986-26-000002","document":"form4-06172026_050656.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000182598626000002/form4-06172026_050656.xml","form_type":"4"}},{"id":1097983,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37291,"kind":"person","name":"Keefer David R","position":1,"cik":"0001825986","reported_name":"Keefer David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-01T17:58:11.000Z","date":"2025-06-27","kind":"grant","planned":false,"acquired":true,"shares":2362,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2362,"derivative":{"exercise_price":4.71,"exercise_date":"2026-06-27","expiration_date":"2035-06-27","underlying":"Common Stock","underlying_shares":2362},"source":{"system":"sec-edgar","filing":"0001415889-25-018640","document":"form4-07012025_050707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588925018640/form4-07012025_050707.xml","form_type":"4"}},{"id":1103915,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37291,"kind":"person","name":"Keefer David R","position":1,"cik":"0001825986","reported_name":"Keefer David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T16:02:49.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":210,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":420,"derivative":{"exercise_price":4.8,"exercise_date":"2026-06-18","expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":210},"source":{"system":"sec-edgar","filing":"0001415889-25-017938","document":"form4-06232025_040645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588925017938/form4-06232025_040645.xml","form_type":"4"}},{"id":1103914,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37291,"kind":"person","name":"Keefer David R","position":1,"cik":"0001825986","reported_name":"Keefer David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T16:02:49.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":210,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":210,"derivative":{"exercise_price":4.8,"exercise_date":"2026-06-18","expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":210},"source":{"system":"sec-edgar","filing":"0001415889-25-017938","document":"form4-06232025_040645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588925017938/form4-06232025_040645.xml","form_type":"4"}},{"id":1612522,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37291,"kind":"person","name":"Keefer David R","position":1,"cik":"0001825986","reported_name":"Keefer David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-28T18:01:38.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":4709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest 100% on February 26, 2025, one year following the grant date."}],"balance_after":4709,"derivative":{"exercise_price":0.357,"expiration_date":"2034-02-26","underlying":"Common Stock","underlying_shares":4709},"source":{"system":"sec-edgar","filing":"0001415889-24-005679","document":"form4-02282024_060230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588924005679/form4-02282024_060230.xml","form_type":"4"}},{"id":1849753,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37291,"kind":"person","name":"Keefer David R","position":1,"cik":"0001825986","reported_name":"Keefer David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-20T18:06:18.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest 100% on June 15, 2024, one year following the grant date."}],"balance_after":5250,"derivative":{"exercise_price":1.85,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001415889-23-009993","document":"form4-06202023_060614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588923009993/form4-06202023_060614.xml","form_type":"4"}},{"id":2218777,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37291,"kind":"person","name":"Keefer David R","position":1,"cik":"0001825986","reported_name":"Keefer David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-30T18:03:23.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest 100% on June 23, 2023, one year following the grant date."}],"balance_after":5250,"derivative":{"exercise_price":4.23,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001415889-22-007089","document":"form4-06302022_110615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922007089/form4-06302022_110615.xml","form_type":"4"}},{"id":2444387,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37291,"kind":"person","name":"Keefer David R","position":1,"cik":"0001825986","reported_name":"Keefer David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T20:12:06.000Z","date":"2022-01-04","kind":"purchase","acquired":true,"shares":5000,"price":5.795,"value":28975.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.75 to $5.80, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. (\"Virios\"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001415889-22-000350","document":"form4-01052022_120151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922000350/form4-01052022_120151.xml","form_type":"4"}},{"id":2657559,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37291,"kind":"person","name":"Keefer David R","position":1,"cik":"0001825986","reported_name":"Keefer David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-23T18:48:06.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 12 equal monthly installments following the grant date."}],"balance_after":7875,"derivative":{"exercise_price":6.5,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001415889-21-003150","document":"form4-06232021_110655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588921003150/form4-06232021_110655.xml","form_type":"4"}},{"id":2888885,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37291,"kind":"person","name":"Keefer David R","position":1,"cik":"0001825986","reported_name":"Keefer David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2021-02-02T00:54:07.000Z","date":"2021-01-28","kind":"exercise","acquired":false,"shares":1602,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Ethica Group, LLC"},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"The Reporting Person provided notice of exercise to the Issuer on January 20, 2021 and the Company authorized the issuance of the shares pursuant to such exercise on January 28, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are owned directly by Ethica Group, LLC (\"Ethica\"), the Reporting Person is managing member of Ethica and may be deemed to beneficially own the securities held directly by Ethica."}],"balance_after":0,"derivative":{"exercise_price":7.8,"exercise_date":"2020-12-16","expiration_date":"2021-01-20","underlying":"Common Stock","underlying_shares":1602},"source":{"system":"sec-edgar","filing":"0001104659-21-010383","document":"tm214953-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465921010383/tm214953-1_4seq1.xml","form_type":"4"}},{"id":2888884,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":37291,"kind":"person","name":"Keefer David R","position":1,"cik":"0001825986","reported_name":"Keefer David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-02T00:54:07.000Z","date":"2021-01-28","kind":"exercise","acquired":true,"shares":1602,"price":7.8,"value":12495.6,"ownership":{"direct":false,"nature":"Ethica Group, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are owned directly by Ethica Group, LLC (\"Ethica\"), the Reporting Person is managing member of Ethica and may be deemed to beneficially own the securities held directly by Ethica."}],"balance_after":7808,"source":{"system":"sec-edgar","filing":"0001104659-21-010383","document":"tm214953-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465921010383/tm214953-1_4seq1.xml","form_type":"4"}}]}